Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae

Morolic acid is a plant‐derived triterpenoid that possesses pharmacological properties such as cytotoxicity, as well as anti‐HIV, anti‐HSV, anti‐inflammatory, and antidiabetic effects. The significant therapeutic properties of morolic acid are desirable in the context of pharmacological and drug dev...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkki: Srisawat, Pisanee (author)
Eará dahkkit: Yasumoto, Shuhei (author), Fukushima, Ery Odette (author), Robertlee, Jekson (author), Seki, Hikaru (author), Muranaka, Toshiya (author)
Materiálatiipa: article
Almmustuhtton: 2020
Fáttát:
Liŋkkat:https://doi.org/10.1002/bit.27357
http://repositorio.ikiam.edu.ec/jspui/handle/RD_IKIAM/360
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
_version_ 1840044847660007424
author Srisawat, Pisanee
author2 Yasumoto, Shuhei
Fukushima, Ery Odette
Robertlee, Jekson
Seki, Hikaru
Muranaka, Toshiya
author2_role author
author
author
author
author
author_facet Srisawat, Pisanee
Yasumoto, Shuhei
Fukushima, Ery Odette
Robertlee, Jekson
Seki, Hikaru
Muranaka, Toshiya
author_role author
collection Repositorio Universidad Regional Amazónica
dc.creator.none.fl_str_mv Srisawat, Pisanee
Yasumoto, Shuhei
Fukushima, Ery Odette
Robertlee, Jekson
Seki, Hikaru
Muranaka, Toshiya
dc.date.none.fl_str_mv 2020-06-02T20:32:53Z
2020-06-02T20:32:53Z
2020
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv Srisawat, P, Yasumoto, S, Fukushima, EO, Robertlee, J, Seki, H, Muranaka, T. Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae . Biotechnology and Bioengineering. 2020; 1– 11. doi.org/10.1002/bit.27357
https://doi.org/10.1002/bit.27357
http://repositorio.ikiam.edu.ec/jspui/handle/RD_IKIAM/360
dc.language.none.fl_str_mv en
dc.publisher.none.fl_str_mv Wiley - V C H Verlag GmbbH & Co.
dc.relation.none.fl_str_mv PRODUCCIÓN CIENTÍFICA-ARTÍCULOS;A-IKIAM-000030
dc.rights.none.fl_str_mv Atribución-NoComercial-SinDerivadas 3.0 Estados Unidos de América
http://creativecommons.org/licenses/by-nc-nd/3.0/us/
info:eu-repo/semantics/openAccess
dc.source.none.fl_str_mv reponame:Repositorio Universidad Regional Amazónica
instname:Universidad Regional Amazónica
instacron:IKIAM
dc.subject.none.fl_str_mv bioactive plant
morolic acid
derived triterpenoid
dc.title.none.fl_str_mv Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Morolic acid is a plant‐derived triterpenoid that possesses pharmacological properties such as cytotoxicity, as well as anti‐HIV, anti‐HSV, anti‐inflammatory, and antidiabetic effects. The significant therapeutic properties of morolic acid are desirable in the context of pharmacological and drug development research, but the low accessibility of morolic acid from natural resources limits its applications. In the present study, we developed a microbial system for the production of morolic acid. Using a combinatorial biosynthesis approach, a novel production pathway was constructed in Saccharomyces cerevisiae by co‐expressing BfOSC2 (germanicol synthase) from Bauhinia forficata and CYP716A49 (triterpene C‐28 oxidase) from Beta vulgaris. Moreover, we reconstructed the cellular galactose regulatory network by introducing a chimeric transcriptional activator (fusion of Gal4dbd.ER.VP16, GEV) to overdrive the genes under the control of the galactose promoter. We also overexpressed truncated HMG1, encoding feedback‐inhibition‐resistant form of 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase 1 and sterol‐regulating transcription factor upc2‐1, to increase the isoprenoid precursors in the mevalonate pathway. Using this yeast system, we achieved morolic acid production up to 20.7 ± 1.8 mg/L in batch culture. To our knowledge, this is the highest morolic acid titer reported from a heterologous host, indicating a promising approach for obtaining rare natural triterpenoids. This article is protected by copyright. All rights reserved.
eu_rights_str_mv openAccess
format article
id IKIAM_5a2e86eaa69bccdd819abc68e8b5b750
identifier_str_mv Srisawat, P, Yasumoto, S, Fukushima, EO, Robertlee, J, Seki, H, Muranaka, T. Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae . Biotechnology and Bioengineering. 2020; 1– 11. doi.org/10.1002/bit.27357
instacron_str IKIAM
institution IKIAM
instname_str Universidad Regional Amazónica
language_invalid_str_mv en
network_acronym_str IKIAM
network_name_str Repositorio Universidad Regional Amazónica
oai_identifier_str oai:repositorio.ikiam.edu.ec:RD_IKIAM/360
publishDate 2020
publisher.none.fl_str_mv Wiley - V C H Verlag GmbbH & Co.
reponame_str Repositorio Universidad Regional Amazónica
repository.mail.fl_str_mv .
repository.name.fl_str_mv Repositorio Universidad Regional Amazónica - Universidad Regional Amazónica
repository_id_str 0
rights_invalid_str_mv Atribución-NoComercial-SinDerivadas 3.0 Estados Unidos de América
http://creativecommons.org/licenses/by-nc-nd/3.0/us/
spelling Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiaeSrisawat, PisaneeYasumoto, ShuheiFukushima, Ery OdetteRobertlee, JeksonSeki, HikaruMuranaka, Toshiyabioactive plantmorolic acidderived triterpenoidMorolic acid is a plant‐derived triterpenoid that possesses pharmacological properties such as cytotoxicity, as well as anti‐HIV, anti‐HSV, anti‐inflammatory, and antidiabetic effects. The significant therapeutic properties of morolic acid are desirable in the context of pharmacological and drug development research, but the low accessibility of morolic acid from natural resources limits its applications. In the present study, we developed a microbial system for the production of morolic acid. Using a combinatorial biosynthesis approach, a novel production pathway was constructed in Saccharomyces cerevisiae by co‐expressing BfOSC2 (germanicol synthase) from Bauhinia forficata and CYP716A49 (triterpene C‐28 oxidase) from Beta vulgaris. Moreover, we reconstructed the cellular galactose regulatory network by introducing a chimeric transcriptional activator (fusion of Gal4dbd.ER.VP16, GEV) to overdrive the genes under the control of the galactose promoter. We also overexpressed truncated HMG1, encoding feedback‐inhibition‐resistant form of 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase 1 and sterol‐regulating transcription factor upc2‐1, to increase the isoprenoid precursors in the mevalonate pathway. Using this yeast system, we achieved morolic acid production up to 20.7 ± 1.8 mg/L in batch culture. To our knowledge, this is the highest morolic acid titer reported from a heterologous host, indicating a promising approach for obtaining rare natural triterpenoids. This article is protected by copyright. All rights reserved.Wiley - V C H Verlag GmbbH & Co.2020-06-02T20:32:53Z2020-06-02T20:32:53Z2020info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfSrisawat, P, Yasumoto, S, Fukushima, EO, Robertlee, J, Seki, H, Muranaka, T. Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae . Biotechnology and Bioengineering. 2020; 1– 11. doi.org/10.1002/bit.27357https://doi.org/10.1002/bit.27357http://repositorio.ikiam.edu.ec/jspui/handle/RD_IKIAM/360enPRODUCCIÓN CIENTÍFICA-ARTÍCULOS;A-IKIAM-000030Atribución-NoComercial-SinDerivadas 3.0 Estados Unidos de Américahttp://creativecommons.org/licenses/by-nc-nd/3.0/us/info:eu-repo/semantics/openAccessreponame:Repositorio Universidad Regional Amazónicainstname:Universidad Regional Amazónicainstacron:IKIAM2023-04-04T08:00:17Zoai:repositorio.ikiam.edu.ec:RD_IKIAM/360Institucionalhttps://repositorio.ikiam.edu.ec/Universidad públicahttps://www.ikiam.edu.ec/https://repositorio.ikiam.edu.ec/oaiEcuador...opendoar:02023-04-04T08:00:17falseInstitucionalhttps://repositorio.ikiam.edu.ec/Universidad públicahttps://www.ikiam.edu.ec/https://repositorio.ikiam.edu.ec/oai.Ecuador...opendoar:02023-04-04T08:00:17Repositorio Universidad Regional Amazónica - Universidad Regional Amazónicafalse
spellingShingle Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae
Srisawat, Pisanee
bioactive plant
morolic acid
derived triterpenoid
status_str publishedVersion
title Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae
title_full Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae
title_fullStr Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae
title_full_unstemmed Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae
title_short Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae
title_sort Production of the bioactive plant‐derived triterpenoid morolic acid in engineered Saccharomyces cerevisiae
topic bioactive plant
morolic acid
derived triterpenoid
url https://doi.org/10.1002/bit.27357
http://repositorio.ikiam.edu.ec/jspui/handle/RD_IKIAM/360